Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting

Hormones and Behavior

Volumn 37, Issue 4, 2000, Pages 335-344

  Lu, Xin Yun ^a   Bagnol, Didier ^a   Burke, Sharon ^a   Akil, Huda ^a   Watson, Stanley J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amygdala; Fasting; Hypothalamus; Orexin hypocretin; OX1R; OX2R

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE RECEPTOR; OREXIN; OREXIN RECEPTOR; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; DIET RESTRICTION; HYPOTHALAMUS NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; SUBTHALAMIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

EID: 0033921449     PISSN: 0018506X     EISSN: None     Source Type: Journal    
DOI: 10.1006/hbeh.2000.1584     Document Type: Article

References (43)

1. Armstrong W. E. The Rat Nervous System. 1995;Academic Press, Sydney.
2. Avrith D., Mogenson G. J. Reversible hyperphagia and obesity following intracerebral microinjections of colchicine into the ventromedial hypothalamus of the rat. Brain Res. 153:1978;99-107.
3. Bagetta G., Priolo E., Nistico G. Dopamine D-2 receptors in the ventral tegmental area mediate behavioural and electrocortical sleep of dopaminergic drugs in rats. Pharmacol. Res. Commun. 20:1988;1091-1092.
4. Bernardis L. L., Bellinger L. L. The dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Res. 434:1987;321-381.
5. Bernardis L. L., McEwen G., Kodis M., Feldman M. J. Pair-feeding of sham-operated controls to rats with dorsomedial hypothalamic lesions: New evidence for an 'organismic' set point. Behav. Brain Res. 26:1987;99-108.
6. Broberger C., De Lecea L., Sutcliffe J. G., Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 402:1998;460-474.
7. Cai X. J., Widdowson P. S., Harrold J., Wilson S., Buckingham R. E., Arch J. R., Tadayyon M., Clapham J. C., Wilding J., Williams G. Hypothalamic orexin expression: Modulation by blood glucose and feeding. Diabetes. 48:1999;2132-2137.
8. Chemelli R. M., Willie J. T., Sinton C. M., Elmquist J. K., Scammell T., Lee C., Richardson J. A., Williams S. C., Xiong Y., Kisanuki Y., Fitch T. E., Nakazato M., Hammer R. E., Saper C. B., Yanagisawa M. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation [see comments]. Cell. 98:1999;437-451.
9. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA. 96:1999;748-753.
10. Davies R., Nakajima S., White N. Enhancement of feeding produced by stimulation of the ventromedial hypothalamus. J. Comp. Physiol. Psychol. 86:1974;414-419.
11. de Lecea L., Kilduff T. S., Peyron C., Gao X., Foye P. E., Danielson P. E., Fukuhara C., Battenberg E. L., Gautvik V. T., Bartlett F. S. 2nd, Frankel W. N., van den Pol A. N., Bloom F. E., Gautvik K. M., Sutcliffe J. G. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA. 95:1998;322-327.
12. Dewasmes G., Duchamp C., Bothorel B., Candas V. Sleep changes in fasting rats after chronic glycerol feeding. Physiol. Behav. 50:1991;537-541.
13. Dewasmes G., Duchamp C., Minaire Y. Sleep changes in fasting rats. Physiol. Behav. 46:1989;179-184.
14. Dube M. G., Kalra S. P., Kalra P. S. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action [In Process Citation]. Brain Res. 842:1999;473-477.
15. Edwards C. M., Abusnana S., Sunter D., Murphy K. G., Ghatei M. A., Bloom S. R. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 160:1999;R7-R12.
16. Elias C. F., Lee C., Kelly J., Aschkenasi C., Ahima R. S., Couceyro P. R., Kuhar M. J., Saper C. B., Elmquist J. K. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron. 21:1998;1375-1385.
17. Guilleminault C., Heinzer R., Mignot E., Black J. Investigations into the neurologic basis of narcolepsy. Neurology. 50:1998;S8-S15.
18. Hahn T. M., Breininger J. F., Baskin D. G., Schwartz M. W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1:1998;271-272.
19. Herberg L. J., Blundell J. E. Lateral hypothalamus: Hoarding behavior elicited by electrical stimulation. Science. 155:1967;349-350.
20. Horvath T. L., Diano S., van den Pol A. N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 19:1999;1072-1087.
21. Ida T., Nakahara K., Katayama T., Murakami N., Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 821:1999;526-529.
22. Kalra S. P., Dube M. G., Pu S., Xu B., Horvath T. L., Kalra P. S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100.
23. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P. J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene [see comments]. Cell. 98:1999;365-376.
24. Mignot E., Nishino S., Sharp L. H., Arrigoni J., Siegel J. M., Reid M. S., Edgar D. M., Ciaranello R. D., Dement W. C. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: Induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems. J. Neurosci. 13:1993;1057-1064.
25. Mondal M. S., Nakazato M., Date Y., Murakami N., Hanada R., Sakata T., Matsukura S. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models. Neurosci. Lett. 273:1999;45-48.
26. Monti J. M., Fernandez M., Jantos H. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology. 3:1990;153-162.
27. Monti J. M., Jantos H., Fernandez M. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur. J. Pharmacol. 169:1989;61-66.
28. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
29. Nisbett R. E. Hunger, obesity, and the ventromedial hypothalamus. Psychol. Rev. 79:1972;433-453.
30. Nishino S., Arrigoni J., Valtier D., Miller J. D., Guilleminault C., Dement W. C., Mignot E. Dopamine D2 mechanisms in canine narcolepsy. J. Neurosci. 11:1991;2666-2671.
31. Nishino S., Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52:1997;27-78.
32. Nishino S., Reid M. S., Dement W. C., Mignot E. Neuropharmacology and neurochemistry of canine narcolepsy. Sleep. 17:1994;S84-S92.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego.
34. Peyron C., Tighe D. K., van den Pol A. N., de Lecea L., Heller H. C., Sutcliffe J. G., Kilduff T. S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
35. Risold P. Y., Griffond B., Kilduff T. S., Sutcliffe J. G., Fellmann D. Preprohypocretin (orexin) and prolactin-like immunoreactivity are coexpressed by neurons of the rat lateral hypothalamic area. Neurosci. Lett. 259:1999;153-156.
36. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R. M., Tanaka H., Williams S. C., Richarson J. A., Kozlowski G. P., Wilson S., Arch J. R., Buckingham R. E., Haynes A. C., Carr S. A., Annan R. S., McNulty D. E., Liu W. S., Terrett J. A., Elshourbagy N. A., Bergsma D. J., Yanagisawa M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
37. Simerly R. B. The Rat Nervous System. 1995;Academic Press, Sydney.
38. Sweet D. C., Levine A. S., Billington C. J., Kotz C. M. Feeding response to central orexins. Brain Res. 821:1999;535-538.
39. Trivedi P., Yu H., MacNeil D. J., Van der Ploeg L. H., Guan X. M. Distribution of orexin receptor mRNA in the rat brain [published erratum appears in FEBS Lett., 1999, 442(1), 122]. FEBS Lett. 438:1998;71-75.
40. van den Pol A. N., Gao X. B., Obrietan K., Kilduff T. S., Belousov A. B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18:1998;7962-7971.
41. Volkoff H., Bjorklund J. M., Peter R. E. Stimulation of feeding behavior and food consumption in the goldfish, carassius auratus, by orexin-A and orexin-B [In Process Citation]. Brain Res. 846:1999;204-209.
42. Vrang N., Larsen P. J., Clausen J. T., Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine- regulated transcript neurons [In Process Citation]. J. Neurosci. 19:1999;RC5.
43. Yamanaka A., Sakurai T., Katsumoto T., Masashi Y., Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res. 849:1999;248-252.